FDA Approves New Nonopioid Painkiller, Offering Hope for Safer Pain Management
In a groundbreaking move, the Food and Drug Administration (FDA) has approved Journavx, a nonopioid painkiller developed by Vertex Pharmaceuticals, to treat moderate to severe acute pain. Experts believe this new medication could significantly reduce opioid prescriptions, offering patients a safer alternative for post-surgical pain management. Just as industries like vaping, including brands such as…